This disclosure relates to the field of ophthalmological surgery devices. In particular, this disclosure relates to macular buckles, methods of their making based on a patient's specific ocular image features, and methods of their insertion to the eye of a patient.
The following includes information that may be useful in understanding the present invention. It is not an admission that any of the information, publications or documents specifically or implicitly referenced herein is prior art, or essential, to the presently described or claimed inventions. All publications and patents mentioned herein are hereby incorporated herein by reference in their entirety.
Multiple macular indentors or “macular buckles” as they are known in the retina surgery community have been previously proposed and used in clinical studies. The earliest macular buckle was developed in 1957 by Dr. Charles Schepens and described in Schepens C L et al., The scleral buckling procedures. I. Surgical techniques and management, AMA Arch. Opthalmol., 1957; 58:797-811. Modifications to these macular buckles were made by Rosengren and Theodonsiadis and described in Rosengren B., The silver plomb method in macular holes, Trans Ophthalmol Soc UK 1966; 86:49-53 and Theodossiadis G P, A simplified technique for the surgical treatment of retinal detachment resulting from macular holes, Lin Monbl Augenheilkd 1973; 162:719-28, respectively. More contemporary versions of macular buckles include suture adjustable positioning, fiber optic verification of position, bendable backbone as well as different geometries and materials. These macular buckles have demonstrated the safety and efficacy of the concept of macular indentation to treat various macular diseases for myopic patients including myopic tranctional maculopathy, macular hole, macular schisis and retinal detachments.
All of the previous concepts in macular buckles involve a one-size-fit-all design concept with some allowing minor adjustment to be made on the fly during surgery. Due to the high amount of variability in the shape, length, and curvature of highly myopic eyes, these one-size-fit-all designs can fit poorly when implanted, cause stability issues, and the accuracy of the placement over the macula region may be inaccurate. Also, in current designs, adjustments made to the device and its placement are highly surgeon-dependent. Further, the device may move after visualization and suturing of the device to the sclera. Long term positional stability of the device is also a concern as the suture may be too lax and the device may slide in different directions after placement. Due to the high level of variations in shape, length and sizes of highly myopic eyes, correct positioning of the device to support the macula is a challenge. These factors lead to variable clinical outcomes for individuals having macular buckle surgeries.
Additive manufacturing can produce end-use components which generally exhibit high geometric configurations and configured applications, including implantable medical devices. At least some known additive manufacturing (AM) processes encompass a variety of forms to cover an entire range of quick-response direct fabrication, typically in a layered format with unprecedented design freedom. AM generally enables the creation of geometries that can be very difficult to machine.
At least some known component geometries can be designed according to the manufacturing method that can be used to machine the final component. At least some known standard computer-aided engineering and design (CAD) tools that are used to produce three-dimensional (3D) models can mimic standard machine shop methods when designing a 3D model to ensure that the components will be manufacturable using standard methods at a reasonable cost.
The embodiments described herein have many attributes and aspects including, but not limited to, those set forth or described or referenced in this Summary. It is not intended to be all-inclusive and the embodiments described herein are not limited to or by the features or embodiments identified in this Summary, which is included for purposes of illustration only and not restriction.
In one aspect, a macular indentor for implantation on an eye of a patient is disclosed. The macular indentor includes a curved backbone extending from a first end to a second end and a raised pad coupled to the first end of the backbone. The raised pad extends inward from an inner face of the backbone such that, when the macular indentor is implanted on the eye, the raised pad applies pressure to the sclera of the eye which contacts the macula of the eye. The geometry of the backbone is configured to match the geometry of the eye by the methods described herein. The fit of the macular indentor to the eye can be confirmed using OCT (optical coherence tomography) imaging of the retina.
In another aspect, this disclosure provides for a method of treating a patient having an ocular condition, the method comprising attaching a macular indentor described herein to the eyeball of the patient. In some aspects, the attachment occurs by suturing. In some aspects, the attachment occurs by contacting a portion or all of the macular indentor with a surgical glue, then contacting the macular indentor to the eyeball and allowing the glue to set. In some aspects, the surgical glue is selected from: ReSure Sealant (polyethylene glycol and trilysine acetate), cyanoacrylate, fibrin glue, Duraseal (polyethylene glycol ester and trilysine), Focalseal (polyethylene glycol acrylate and photoinitiator, cured by blue light), L-β-3,4-dihydroxyphenyl-α-alanine (DOPA), chondroitin sulfate reacting with glycidyl methacrylate, BioGlue (bovine albumin and glutaraldehyde), Progel (human albumin and a PEG crosslinker with two NHS activated ester groups), fibrin (Tisseel (Baxter Inc., Denmark), Evicel (Ethicon Inc., Bridgewater, N.J.), Crosseal (OMRIX Biopharmaceuticals Ltd. Israel), and Hemaseel (Heamacure Corp., Canada)), Coseal (Cohesion Technologies, Inc., Palo Alto, Calif.) (PEG-based sealant, which is made of two 4-arm PEG with glutaryl-succinimidyl ester and thiol terminal groups), FocalSeal, and AdvaSeal (Ethicon Inc., Johnson & Johnson Medical KK). In some aspects, the ocular condition is selected from: myopic tractional maculopathy, macular hole, myopic foveoschisis, myopic tractional maculopathy, posterior staphyloma and macular hole with retinal detachment. In some aspects, the method further comprises confirming the proper placement of the macular indentor on the eyeball. The placement of the macular indentor can be confirmed with the use of a fiber optic which is removably attached to the backbone of the macular indentor (e.g., via sutures), and the fiber optic is configured to emit light at the tip of the fiber optic and detected by indirect ophthalmoscope during surgery. The fiber optic can be pulled to extract the fiber optic after implantation of the macular indentor.
In some aspects, this disclosure provides for the use of a macular indentor described herein for treating a macular disease in a patient by surgically suturing the macular indentor to the eyeball of said patient.
In another aspect, a method includes receiving a first image of an eye of a patient. The method further includes delineating the outline of a globe of the eye. The method further includes developing a curve that matches the outline of the globe of the eye. The method further includes generating geometry of a macular indentor such that a portion of the macular indentor follows the curve that matches the outline of the globe of the eye.
In another aspect, a system for designing and manufacturing by additive manufacturing methods a patient-specific macular indentor is disclosed. The system comprises: (a) a computer unit which receives a first image of an eye of a patient, delineates the outline of a globe of the eye, develops a curve that matches the outline of the globe of the eye, and generates a geometry of a macular indentor such that a portion of the macular indentor follows the curve that matches the outline of the globe of the eye, and (b) an additive manufacturing device which creates an additively-manufactured macular indentor matching the generated geometry.
The drawings form part of the present specification and are included to further demonstrate certain aspects of the embodiments described herein. These embodiments may be better understood by reference to one or more of the following drawings in combination with the detailed description.
This description of the exemplary embodiments is intended to be read in connection with the accompanying drawings, which are to be considered part of the entire written description. The drawing figures are not necessarily to scale and certain features may be shown exaggerated in scale or in somewhat schematic form in the interest of clarity and conciseness. In the description, relative terms such as “horizontal,” “vertical,” “up,” “down,” “top” and “bottom” as well as derivatives thereof (e.g., “horizontally,” “downwardly,” “upwardly,” etc.) should be construed to refer to the orientation as then described or as shown in the drawing figure under discussion. These relative terms are for convenience of description and normally are not intended to require a particular orientation. Terms including “inwardly” versus “outwardly,” “longitudinal” versus “lateral” and the like are to be interpreted relative to one another or relative to an axis of elongation, or an axis or center of rotation, as appropriate. Terms concerning attachments, coupling and the like, such as “connected” and “interconnected,” refer to a relationship wherein structures are secured or attached to one another either directly or indirectly through intervening structures, as well as both movable or rigid attachments or relationships, unless expressly described otherwise. The term “operatively connected” is such an attachment, coupling or connection that allows the pertinent structures to operate as intended by virtue of that relationship.
As used herein, ocular directionality terms such as “superior”, “inferior”, “temporal”, and “nasal” are understood to have their normal meaning in the art and refer to the relative positions of the eyeball.
Macular Indentors
The present disclosure is related to macular indentors used in macular buckling surgeries to treat pathologies including myopic tractional maculopathy, macular hole, myopic foveoschisis, myopic tractional maculopathy, posterior staphyloma and macular hole with retinal detachment. The macular indentors described herein are configured to fit to a specific patient's eye geometry to improve the positioning and retention of the indentor. The fact that the macular indentor is configured to fit to the patient's eye geometry allows for the inclusion of additional retention features to provide additional support to retain the indentor in place. This description also discloses methods of designing and manufacturing such indentors.
The indentors described herein may support the macula from the scleral side of the eye by creating an indentation of the macula. The indentor may be formed using additive manufacturing (e.g., 3D printing) and may be configured to fit the curvature, shape, length and size of the individual eye being treated. The geometry of the indentor may be determined using image guidance from Bscan ultrasonography, A-scan ultrasonography, 3D ultrasounds, and/or ocular coherence tomography.
Additive manufacturing the indentor based on the eye geometry allows for improved accuracy in placement and increased stability of the device. The configured geometry of the indentor may also decrease inter-surgeon variability on results of the surgery (i.e., dependency on surgical skill). Because the geometry of the macular indentors described herein may be configured designed to fit to the patient's eye, the device may fit smoothly along the sclera and follow the natural curvature of the individual eye. Like a foot orthotic or a dental implant that is configured to fit the geometric shape of the appropriate portion of the patient, the placement of the indentor is more repeatable than with prior art indentors, thereby reducing the variability on the outcome of the surgery based on the skill of the surgeon. The configured sizing of the indentor also increases the likelihood that the indentor is correctly positioned. Further, such an indentor may increase the long term positional stability of the indentor, reducing the risk of slippage or extrusion after implantion.
In one embodiment, a macular indentor for implantation on an eye of a patient is disclosed. The macular indentor includes a curved backbone extending from a first end to a second end and a raised pad coupled to the first end of the backbone. The raised pad extends inward from an inner face of the backbone such that, when the macular indentor is implanted on the eye, the raised pad applies pressure to the sclera of the eye which contacts the macula of the eye. In some embodiments, the sclera of the eye to which the pad applies pressure to is adjacent to the macula of the eye. In some embodiments, the sclera of the eye to which the pad applies pressure to ranges from 0 to 2 mm of the macula of the eye. The geometry of the backbone is configured to match the geometry of the eye by the methods described herein.
In some embodiments, the macular indentor further comprises at least one arm extending from the second end of the backbone, wherein the arm is configured to match the geometry of the eye. The configuration of the multiple arms can be situated such that a leverage is applied against the peripheral outline of the eyeball so as to keep the bulb positioned in the same location despite movement of the eyeball. In some embodiments, the at least one arms extends orthogonally to a mid-line of the backbone. In some embodiments, when there are two or more arms, they can be configured to be from 5 to 180 degrees from each other. In some embodiments, the at least one arm can comprise two arms extending from the backbone in opposite directions such that the arms and the backbone form a cross shape.
In some embodiments, the macular indentor further comprises at least one aperture which is configured to receive a suture to secure the macular indentor to the eye. The aperature can be of a shape selected from round, oval, polygon (wherein the polygon has from 3 to 20 sides), or multipoint star-shaped (wherein the star has from 4 to 64 points). In some embodiments, the macular indentor can comprise one or a plurality of apertures extending through said indentor. In some embodiments, at least one of the apertures is positioned at the intersection of the arms and the midline of said indentor.
In some embodiments, the thickness of the raised pad (also referred to herein as the “bulb”) can be configured based on a macular detachment height, and can range from 0.3 mm to 5 mm In some embodiments, the width of the backbone and/or arms can range from 2 mm to 7 mm In some embodiments, the thickness of the backbone and/or arms can range from 0.2 mm to 4.5 mm.
In some embodiments, the cross-section of the raised pad can be semi-spherical and can be configured to create a semi-spherical indentation of the macula. In some embodiments, the cross-section of the raised pad is semi-oval (selected from length-wise or width-wise) and can be configured to create a semi-oval indentation of the macula. In some embodiments, the cross-section of the raised pad can be a parallelogram and be configured to create a flat indention of the macula.
In some embodiments, the macular indentor is constructed from at least one material selected from the group consisting of: titanium, cobalt, nylon, Teflon (polytetrafluoroethylene), polyurethane, high density polyethylene (HDPE), polypropylene, and stainless steel. In some embodiments, the macular indentor is created byh a process comprising additive-layered manufacturing (also referred to herein as “3D printing”). In some embodiments, the macular indentor can be coated with a silicone covering.
One embodiment of an indentor 100 is shown in
The backbone 102 extends from the first end 102a to a second end 102b and extends along a curved path. The curvature and length of the backbone 102 is determined based on the geometry of the eye to which the indentor 100 is to be affixed, as described further herein. The backbone 102 includes an inner face 102 that is configured to be positioned against the eye (e.g., against the sclera).
As noted above, the raised pad 104 is coupled to the first end 102a of the backbone 102. As described further herein, in some embodiments, the backbone 102 and raised pad 104 are formed together—for example, using an additive manufacturing process. In other embodiments, the backbone 102 and the raised pad 104 may be joined using adhesive, welding, or other methods. The raised pad 104 may be substantially circular in cross-section and may protrude inward from the inner face 108 of the backbone 102 such that, when the indentor 100 is implanted, the raised pad 104 extends inward toward the macula to apply localized pressure on the eye. The raised pad 104 may be, for example, dome shaped. The amount that the raised pad 104 extends inward from the inner face 108 of the backbone 102 can be determined based on the amount of pressure that the surgeon wishes to apply to the eye to treat the pathology and the geometry of the eye (as determined based on images captured as described herein).
The arms 106 may extend from the second end 102b of the backbone 102. In some embodiments, the indentor 100 includes two arms 106 extending from the backbone 102 and away from one another. In some embodiments, the indentor 100 includes a plurality of arms 106 extending from the backbone 102, wherein the number of arms can be one to eight. In some embodiments, the arms 106 extend orthogonally to a midline 110 of the backbone 102, as shown in
The indentor 100 may be sutured to the sclera—for example, with a mattress or X stitch—at various points including, for example, at the arms 106 or along the backbone 102 of the indentor 100. The sutures may help retain the indentor 100 in position and prevent movement after implantation. In some embodiments, a permanent suture may be used to secure the backbone 102 to the sclera. In various embodiments, the indentor 100 may be completely explantable in case of infection or incorrect positioning.
The indentor 100 may be constructed of any appropriate material. For example, the indentor 100 may be constructed of a medical grade implant material such as, for example, titanium, cobalt, stainless steel or plastic (e.g., nylon). In some embodiments, the indentor 100 is constructed from polyurethane (e.g., by additive manufacturing). Constructing the indentor 100 of a material that can be used in an additive manufacturing process allows the indentor 100 to be manufactured quickly after imaging and prior to surgery. Further, the indentor 100 may include a silicone covering. The covering may be applied after forming the indentor 100 via additive manufacturing, for example. In various embodiments, the indentor 100 may be constructed of a material that is sterilizable. In some embodiments, the indentor is made of a material selected from: titanium, nickel-titanium alloy (nitinol), gold, platinum, silver, iridium, tantalum, tungsten, cobalt, cobalt-chrome alloy, nylon, Teflon (polytetrafluoroethylene), polyurethane, high density polyethylene (HDPE), polypropylene, and stainless steel.
Methods of Measuring and Constructing a Macular Indentor Configured to Fit to the Eyeball of a Patient
In another embodiment, this disclosure provides for a method for generating a simulated geometry of a macular indentor specific to a measured eyeball of a patient, comprising: receiving a first image of an eye of a patient; delineating the outline of a globe of the eye; developing a curve that matches the outline of the globe of the eye; and generating geometry of a macular indentor such that a portion of the macular indentor follows the curve that matches the outline of the globe of the eye from a range of 0 to 2 mm at any point along the outline of the globe of the eye.
In some embodiments, the first image can be selected from an axial B-scan ultrasonography image or an axial A-scan ultrasonography image. In some embodiments, a plurality of images can be obtained of the eye, wherein the images are from the same imaging technique or different imaging techniques, and wherein the images are from the same direction or different directions. When the imaging is from different directions, the angle by which the two or more directions can vary from a range of 1 degree to 45 degrees.
In some embodiments, the method can comprise receiving a second image of the eye of the patient. The second image can be selected from a transverse B-scan ultrasonography image and/or an A-scan ultrasonography image. In some embodiments, the first and second images can be from the same imaging type or different imaging types. In some embodiments, the method can further comprise developing a second curve based on the outline of the globe of the eye in the second image.
In some embodiments, the method can further comprise receiving a third image of the eye of the patient, wherein the third image is an A-scan ultrasonography image, and wherein the length of the macular indentor is determined based on the third image.
In some embodiments, developing the curve can comprise identifying boundary points on the globe of the eye and fitting the curve to the boundary points.
In some embodiments, fitting the curve can comprise cubic spline interpolation.
In some embodiments, the method can further comprise receiving a fourth image of the eye of the patient, wherein the fourth image is an optical coherence tomography image showing a macular detachment, and wherein the thickness of the pad is determined, at least partially, based on a height of the macular detachment.
In some embodiments, the method can further comprise obtaining an optical coherence tomography image of the eye, and determining the size of a raised pad of the macular indentor based on a height of the macular elevation or detachment on the optical coherence tomography image.
In some embodiments, the method can further comprise forming the macular indentor using additive manufacturing.
Methods of designing and manufacturing an indentor 100 according to the embodiments described above will now be described. Images of the eye to which the indentor 100 will be affixed may be generated in order to allow the indentor 100 to be configured to the anatomy of the patient's eye.
One embodiment of a method of determining a geometry of an indentor is illustrated by the flowchart in
As used herein, the term “B-scan ultrasonography” refers to an ultrasonic-based imaging system to obtain structural ocular features. Representative examples of B-scan ultrasonography are further discussed in Aironi, V. et al, Indian J Radiol Imaging. 2009 May; 19(2): 109-115, the contents of which are herein incorporated by reference.
At step 304, transverse images of the eye are acquired using B-scan ultrasonography (brightness scan ultrasonography) at the equator of the eye.
At optional step 306, images of the eye may be captured using A-scan ultrasonography (i.e., amplitude scan ultrasonography). These images can be used to determine the length of the eye, and/or confirm the transverse images obtained from B-scan imaging. The information regarding the length of the eye can be used to determine an optimum length of the indentor 100 (e.g., the backbone 102). In some embodiments, no A-scan imaging is performed.
At optional step 308, images of the eye may be acquired using ocular coherence tomography. An exemplary image is provided in
It should be understood that other imaging modalities can optionally be used to determine the geometry of the eye and/or confirm the eye measurements from the aforementioned modalities. For example, 3D ultrasound images can be used to determine geometry information for the entire globe structure (as compared to slices obtained using 2D ultrasound). Using 3D ultrasound may be used in addition to the imaging modalities described above or may be used in substitution for one or more of the above-described imaging modalities.
At step 310, the outline of the globe of the eye in the B-scan ultrasonography images is delineated using image segmentation techniques. The image segmentation may be performed manually—for example, by the surgeon or designee—or may be performed automatically using computer-implemented methods. As used herein, the term “image segmentation” refers to the process of partitioning a digital image into multiple segments (sets of pixels, also known as image objects), such that a set of segments will collectively cover the entire image, or a set of contours extracted from the image (Bucking T M, Hill E R, Robertson J L, Maneas E, Plumb A A, Nikitichev D I (2017) From medical imaging data to 3D printed anatomical models. PLoS ONE 12(5): e0178540. https://doi.org/10.1371/journal.pone.0178540; Mamta Juneja, Niharika Thakur, Dinesh Kumar, Ankur Gupta, Babandeep Bajwa, Prashant Jindal, Accuracy in dental surgical guide fabrication using different 3-D printing techniques, Additive Manufacturing, Volume 22, 2018, Pages 243-255).
At step 312, curve-fitting techniques are used to determine the anatomy of the globe of the eye. The curve fitting may be done manually or may be fully- or semi-automated. For example, on the 45 degree axial B-scan image obtained at step 302, 8-16 boundary points may be selected along the outline of the sclera. At least one boundary point may be selected in the macular region (e.g, the posterior portion of the eye). At least one boundary point may be selected at the equator of the eye. One or more boundary points may also be selected 1-2 mm anterior to the equator to ensure that the arms 106 are properly positioned and dimensioned. The remaining boundary points may be spaced equidistant in a range from 1-2 mm on the globe. After placement of the boundary points, a cubic spline interpolation technique may be used to fit a curve between each of the boundary points. The curve may satisfy the following equation:
S
n(x)=anx3+bnx2=cnx+dn
By solving the system of n equations, where n is the number of boundary points selected (either manually or automatically), a cubic spline curve is obtained for the length of the indentor 100 (i.e., the anterior to posterior distance).
The curve formed using the axial B-scan image can be used to determine the curvature of the backbone 102 of the indentor 100. In some embodiments, the formed curve can be confirmed by A-scan imaging.
Similarly, on the transverse B-scan image obtained at step 306, boundary points may be positioned along the globe at the position at which the arms 106 will be positioned. For example, 5-10 boundary points may be positioned along the desired location of the arms 106. These boundary points may be selected manually or automatically by a computer. A cubic spline interpolation method can be used to connect the boundary points on the transverse B scan image. The two points that define the boundary of the curve can be used to determine the length and curvature of the arms 106. In some embodiments, the total length of the arms 106 may be in a range of 3-5 mm.
At step 314, the geometry of the indentor 100 is determined based on the anatomy of the eye, ascertained from the images acquired of the eye and the curve fitting described above. The two curves following the geometry of the globe of the eye (i.e., based on the axial and transverse B-scan images) are overlaid. Both curves are extruded in thickness and in width to generate the geometry of the backbone 102 and the arms 106 of the indentor 100. In some embodiments, the indentor 100 has a thickness range from 1-2 mm and width of the backbone 102 is between about 3 mm and about 6 mm. In some embodiments, the width of the backbone is between about 2 mm and about 7 mm.
The thickness and geometry of the raised pad 104 can be designed based on the clinical scenario. For example, the raised pad 104 may be semi-spherical with a radius of about 2-8 mm. The geometry of the raised pad 104 may be determined based on the ocular coherence tomography image quantifying the macular elevation.
Upon completion of the configured image-based design of the indentor 100, additive manufacturing (e.g., 3D printing, fused deposition modeling or direct metal laser sintering) may be used to manufacture the indentor 100. A silicone rubber covering may be added to coat the indentor 100. The indentor 100 may be sterilized prior to implantation. By manufacturing the indentor 100 using additive manufacturing, a configured indentor may be manufactured quickly and relatively inexpensively prior to implementation.
In various embodiments, a method of implanting the indentor 100 includes a making limited conjunctival peritomy at the superotemporal quadrant. The superior and temporal recti muscles are isolated. Tenon adhesions are cleared in the superotemporal quandrant. The indentor 100 is placed along the superotemporal quadrant and should fit along the natural curvature of the eye. The indentor 100 is sutured to the sclera with permanent sutures such as nylon or mersilene sutures along the backbone 102 and/or on the arms 106. Correct placement of the indentor 100 and indentation effect is verified by direct visualization and/or with indirect ophthalmoscopy. The conjunctiva is then closed with sutures.
Methods of Treatment
In some embodiments, this disclosure provides for a method of treating a patient having a macular disease, the method comprising attaching a macular indentor described herein to the eyeball of the patient.
As used herein, the term “patient” refers to a mammal having a macular disease. The mammal can be selected from a human, monkey, horse, rabbit, mouse, rat, pig, dog, or cat. In preferred embodiments, the patient is a human.
In some embodiments, the attachment occurs by suturing. In some embodiments, the attachment occurs by contacting a portion or all of the macular indentor with a surgical glue, then contacting the macular indentor to the eyeball and allowing the glue to set. In some embodiments, the surgical glue is selected from: ReSure Sealant (polyethylene glycol and trilysine acetate), cyanoacrylate, fibrin glue, Duraseal (polyethylene glycol ester and trilysine), Focalseal (polyethylene glycol acrylate and photoinitiator, cured by blue light), L-β-3,4-dihydroxyphenyl-α-alanine (DOPA), chondroitin sulfate reacting with glycidyl methacrylate, BioGlue (bovine albumin and glutaraldehyde), Progel (human albumin and a PEG crosslinker with two NHS activated ester groups), fibrin (Tisseel (Baxter Inc., Denmark), Evicel (Ethicon Inc., Bridgewater, N.J.), Crosseal (OMRIX Biopharmaceuticals Ltd. Israel), and Hemaseel (Heamacure Corp., Canada)), Coseal (Cohesion Technologies, Inc., Palo Alto, Calif.) (PEG-based sealant, which is made of two 4-arm PEG with glutaryl-succinimidyl ester and thiol terminal groups), FocalSeal, and AdvaSeal (Ethicon Inc., Johnson & Johnson Medical KK).
In some embodiments, the macular disease is selected from: myopic tractional maculopathy, macular hole, myopic foveoschisis, myopic tractional maculopathy, posterior staphyloma and macular hole with retinal detachment. In some embodiments, the method further comprises confirming the proper placement of the macular indentor on the eyeball. The confirmation can be established by a method comprising OCT imaging of the retina.
In some embodiments, the macular indentor can further comprise a sterile fiber optic cable which can emit light at the tip of the fiber optic. The fiber optic cable (also referred to herein as “fiber optic” or “fiber optic fiber”) can be removably connected to the backbone of the macular indentor. In some embodiments, the removable connection can be by way of tying the fiber optic cable to the indentor backbone by way of a suture. In some embodiments, the relative position of the tip of the fiber optic can be configured so as to be at or about at the same region as the bulb. The lighted tip will allow verification of the proper placement of the device to the macular region by viewing with an indirect ophthalmoscope during surgery. The fiber optic can be pulled out to extract the fiber optic after the implanted macular indentor is properly placed and sutured.
Systems
In some embodiments, this disclosure provides for a system for creating a patient-specific macular indentor, the system comprising:
In some embodiments, the additive manufacturing device can be any of the AM-devices described herein. In some embodiments, the system further comprises a software file storing the data describing the geometry of the macular indentor. In some embodiments, the software file storing the data describing the geometry of the macular indentor can be recognized by the additive manufacturing device to construct a physical object of the designed macular indentor.
In some embodiments, the computer unit can perform operations in digital electronic circuitry, integrated circuitry, specially designed application specific integrated circuits (ASICs), field programmable gate arrays (FPGAs) computer hardware, firmware, software, and/or combinations thereof. These various aspects or features can include implementation in one or more computer programs that are executable and/or interpretable on a programmable system including at least one programmable processor, which can be special or general purpose, coupled to receive data and instructions from, and to transmit data and instructions to, a storage system, at least one input device, and at least one output device. In some embodiments, the eyeball images can be transmitted to the computer unit by the at least one input device.
These computer programs, which can also be referred to programs, software, software applications, applications, components, or code, include machine instructions for a programmable processor, and can be implemented in a high-level procedural language, an object-oriented programming language, a functional programming language, a logical programming language, and/or in assembly/machine language. As used herein, the term “machine-readable medium” refers to any computer program product, apparatus and/or device, such as for example magnetic discs, optical disks, memory, and Programmable Logic Devices (PLDs), used to provide machine instructions and/or data to a programmable processor, including a machine-readable medium that receives machine instructions as a machine-readable signal. The term “machine-readable signal” refers to any signal used to provide machine instructions and/or data to a programmable processor. The machine-readable medium can store such machine instructions non-transitorily, such as for example as would a non-transient solid-state memory or a magnetic hard drive or any equivalent storage medium. The machine-readable medium can alternatively or additionally store such machine instructions in a transient manner, such as for example as would a processor cache or other random access memory associated with one or more physical processor cores.
In some embodiments, the computer program can be deployed to be executed on one computer or a plurality of computer or processing units at one site or distributed across multiple sites and interconnected by a communication network.
In some embodiments, the computer program used to perform the equations and methods described herein can further comprise writing a file. In some embodiments, a file can be a digital file, (e.g., stored on a hard drive, SSD, CD, or other tangible, non-transitory medium). A file can be sent from one device to another over the communication network as packets being sent from a server to a client.
Writing a file can comprise transforming a tangible, non-transitory computer-readable medium, for example, by adding, removing, or rearranging particles (e.g., with a net charge or dipole moment) into patterns of magnetization by read/write heads, the patterns then representing new collocations of information desired by, and useful to, the user. In some embodiments, writing involves a physical transformation of material in tangible, non-transitory computer readable media with certain properties such that magnetic read/write devices can then read the new and useful collocation of information. In some embodiments, writing a file comprises using flash memory such as NAND flash memory and storing information in an array of memory cells include floating-gate transistors. Methods of writing a file are well-known in the art and, for example, can be invoked automatically by a program from software or from a programming language.
Any of the electronic devices and/or components mentioned above in this system, with the associated interfaces, may be controlled and/or coordinated by operating system software, such as Windows OS (e.g. Windows XP, Windows 8, Windows 10, Windows Server, etc.), Windows CE, Mac OS, iOS, Android, Chrome OS, Unix, Linux, VxWorks, or other suitable operation systems. In other embodiment, the said electronics may be controlled by a proprietary operating system. Conventional operating systems control and schedule system processes for execution, perform memory management, provide file system, networking, I/O services, and provide an user interface functionality, such as a graphical user interface (GUI), among other systems and/or devices.
Additive Manufacturing Systems
The macular indentors of this disclosure can be constructed on any additive manufacturing system capable of manipulating metallic, semi-metallic, or alloyed materials. In some embodiments, additive manufacturing includes several different unique processes. Types of additive manufacturing processes include: laser engineered net shaping (LENS), directed light fabrication (DLF), direct metal deposition (DMD), and laser deposition (LD). Laser deposition in combination with rotational deposition allows for the production of metal compositional gradients radially from the center of a part by a process known as radial additive manufacturing (RAM) with functionally graded materials.
In some embodiments, the RAM process begins with a computer-generated model (CAD) as an input into a program that transforms the part's geometry into a programmable set of pathways that define the movement of the components within an additive manufacturing machine. The two main components of the additive manufacturing machine are a base and the nozzle. The part is constructed onto the base, and the nozzle is the component that utilizes the laser and material feed systems. Both the base and nozzle may be dictated by multiple-axis controls which allow for angular deposition, thereby removed the need for support material. The machine prints by feeding a continuous supply of metal or ceramic powder into the focal zone of a laser which melts the powder. The melted powder forms a melt pool and is deposited along the surface of the part as the laser moves along a predefined path. The melt pool quickly solidifies upon cooling so that the next layer may be added. Successive layers are printed until an entire part is produced. A 3-D CAD model of the conformal cooling molds described herein can be generated using AutoCAD, and converted into the appropriate file format for the additive-manufacturing system. The system can be a direct metal laser sintering (DMLS) powder bed 3-D printer. The build material can be titanium powder (CarTech® Puris Ti-6Al-4V Titanium Powder, Carpenter Technology Corp., USA). The additive manufacturing build instrument can be the EOS M 290 (EOS, Germany) The laser write speed can be varied and limited to a maximum of 7 meters per second. The laser can be a Yb-fiber laser operating at 400 W. The laser focus diameter is 100 microns. The step height can be varied between 20 to 40 microns.
A method for creating a macular indentor made by 3-D printing (additive manufacturing) methods of this disclosure was performed from a rabbit eye model. First, coronal (
In the alternative, when scanned dimensions were not fully describing the ocular features of the patient, the following parameters were set for the macular indentor (
In the scans, “OD” means it was a scan of the right eye and “OS” was for the left eye.
The images were then imported into the Materialise Mimics Research software (Materialise, NV, Europe), using a 1×1×1 scan resolution. The equatorial distance on the 2D image was measured and divided (the original measurement percentage of the measured distance) to obtain the scan resolution required for the scaled import (isometric). The orientation of the imported images was depicted in
Next, a spline was created and overlayed using the points provided in the images. For the sagittal scan, interpolate the last few points to ensure there was no convex curvature, and only a smooth concave curve. The colored features in the images associated with geometric features are: the brown point was the anchor/end of the spline, the yellow point was the start of the spline, and the green point was a point that must be true on the spline (
Next, the splines were swept using the sketch tool within the software program to set the width and thickness (
A Boolean Union was then applied so as to separate the surfaces to be more uniform (mark and fill hole freeform on the edges) (
Candidate bulb sizes were then created and overlayed on the sagittal B scan (
Once the bulb size was determined, cut the sphere to match the curvature and to become an arc rather than a sphere (
The models of the parts were then merged and all edges were rounded (using a fillet radius of 0.2 mm in some embodiments) (
The edges were then rounded, remeshed, and smoothed (
The macular indentor made by the method described in Example 1 was implanted onto the eyeball of an anaesthetized male New Zealand White Rabbit (2.5 kg) which had been previously imaged by A-scan and B-scan ultrasonography to design and create a macular indentor configured to fit the eyeball of the patient.
As shown in
As shown in
In some embodiments, the impact of the macular indentor can be further confirmed with fundus imaging which will demonstrate the shape and position of the macular indentor bulb on the retina.
In some embodiments, the macular indentor can further comprise a sterile lighted fiber optic that is retractable after implantation. The lighted tip will allow verification of the proper placement of the device to the macular region by viewing with an indirect ophthalmoscope during surgery. The fiber optic can be tied with a vicryl suture to the backbone of the device and can simply be pulled out after the implant is properly placed and sutured. In some embodiments, the fiber optic can be coated with a lubricant (e.g., polyethylene glycol, MW 500 to 50,000) to make the fiber optic extraction more facile.
The preceding merely illustrates the principles of various embodiments of the disclosure. It will thus be appreciated that those skilled in the art will be able to devise various arrangements which, although not explicitly described or shown herein, embody the principles of the invention and are included within its spirit and scope. Furthermore, all examples and conditional language recited herein are principally intended expressly to be only for pedagogical purposes and to aid the reader in understanding the principles of the invention and the concepts contributed by the inventors to furthering the art, and are to be construed as being without limitation to such specifically recited examples and conditions. Moreover, all statements herein reciting principles, aspects, and embodiments of the invention, as well as specific examples thereof, are intended to encompass both structural and functional equivalents thereof. Additionally, it is intended that such equivalents include both currently known equivalents and equivalents developed in the future, i.e., any elements developed that perform the same function, regardless of structure.
All numbers expressing quantities or parameters used in the specification are to be understood as additionally being modified in all instances by the term “about”. Notwithstanding that the numerical ranges and parameters set forth, the broad scope of the patient matter presented herein are approximations, the numerical values set forth are indicated as precisely as possible. For example, any numerical value may inherently contain certain errors, evidenced by the standard deviation associated with their respective measurement techniques, or round-off errors and inaccuracies.
This application claims priority to U.S. Provisional Application Ser. No. 62/993,608, filed Mar. 23, 2020, the contents of which are herein incorporated in its entirety.
Number | Date | Country | |
---|---|---|---|
62993608 | Mar 2020 | US |